Topic
Asian access
Page 4 of 15 — Japanese approval and clinic pricing, Korean clinic culture, Singapore, Hong Kong, and the Indian generics landscape.
Messages — page 4 of 15
tokyo_taperare the indian products the same compounds or something else entirely#asia · 2025-09-19week_three_wallas of about a year ago korea had the shortest path from deciding to starting of anywhere members here had described#asia · 2025-09-19week_three_wallhow careful should i be about the claims on an indian generic#asia · 2025-09-19week_three_wallsingapore was reported in here at around 400 to 600 singapore dollars a month a year or so ago, prescription only#asia · 2025-09-19week_three_walla member in hong kong and a member in singapore compared the same dose and came out about forty percent apart#asia · 2025-09-19underfill_umakorea has a clinic culture where this is straightforward to obtain, and members reported that as both a convenience and a…#asia · 2025-09-21factory_direct_fijapan being expensive despite the approval is the pattern. approval sets the licence and the pricing system sets the price#asia · 2025-09-21factory_direct_fijapan approved it#asia · 2025-09-21coa_or_copehong kong, is it pharmacy or clinic in practice#asia · 2025-09-21travel_cooleris it easier to get seen about this in korea than in europe#asia · 2025-09-21quiet_head_qii treat a claim about an indian generic the way i treat any claim about any product. get a lot number and get it tested#asia · 2025-09-21quiet_head_qithe indian landscape is qualitatively different from research supply, it is a licensed pharmaceutical industry, and that is…#asia · 2025-09-21invoice_mismatchgetting seen in korea was faster than any route a uk member described at the time we were both describing it#asia · 2025-09-26invoice_mismatchas of about a year ago korea had the shortest path from deciding to starting of anywhere members here had described#asia · 2025-09-26secretagogue_syhong kong members reported both clinic and pharmacy routes and a wide price range between the two#asia · 2025-09-28secretagogue_sythe honest position on india is that i have seen good material and bad material and the paperwork told me nothing either way#asia · 2025-09-28manila_meniscusindia has a real generics manufacturing base and a real domestic market. what a specific product is, and whether it matches…#asia · 2025-09-28manila_meniscuskorea has a clinic culture where this is straightforward to obtain, and members reported that as both a convenience and a…#asia · 2025-09-28snac_and_waterthe indian landscape is qualitatively different from research supply, it is a licensed pharmaceutical industry, and that is…#asia · 2025-09-28bengaluru_bacgetting seen in korea was faster than any route a uk member described at the time we were both describing it#asia · 2025-09-30monoisotopici was wrong about japanese pricing by a factor of two when i quoted it in here, because i was quoting a clinic and somebody…#asia · 2025-09-30quiet_head_qihong kong, is it pharmacy or clinic in practice#asia · 2025-09-30ms_ms_miraindia has a real generics manufacturing base and a real domestic market. what a specific product is, and whether it matches…#asia · 2025-10-03sgp_subqjapan approved it#asia · 2025-10-03bengaluru_bacanyone in japan paying out of pocket and what does that look like#asia · 2025-10-03sgp_subqa korean member said their clinic visit took under an hour end to end, which is not a claim about the quality of the…#asia · 2025-10-03sgp_subqdoes anyone in hong kong want to compare prices#asia · 2025-10-03sgp_subqthe honest position on india is that i have seen good material and bad material and the paperwork told me nothing either way#asia · 2025-10-03bengaluru_bacanyone compared a japanese pharmacy price against a private clinic in the region#asia · 2025-10-05bengaluru_backorea has a clinic culture where this is straightforward to obtain, and members reported that as both a convenience and a…#asia · 2025-10-05tokyo_taperi was wrong about japanese pricing by a factor of two when i quoted it in here, because i was quoting a clinic and somebody…#asia · 2025-10-05tokyo_taperhong kong members reported both clinic and pharmacy routes and a wide price range between the two nobody here can tell you…#asia · 2025-10-05question_queueis japan expensive because of the approval or in spite of it#asia · 2025-10-05tokyo_tapera korean member said their clinic visit took under an hour end to end, which is not a claim about the quality of the assessment#asia · 2025-10-05tokyo_taperjapan approved it for both indications a while ago as i understood it, and the approval did not make it cheap, i could be wrong#asia · 2025-10-05secretagogue_sycoming back to this a member in hong kong and a member in singapore compared the same dose and came out about forty percent…#asia · 2025-10-05month_six_mesingapore customs, is a personal quantity fine#asia · 2025-10-08triple_ag_tomkorea is fast#asia · 2025-10-08month_six_meanyone compared a japanese pharmacy price against a private clinic in the region#asia · 2025-10-08triple_ag_tomis the korean clinic route cheaper than a pharmacy elsewhere#asia · 2025-10-08secretagogue_sya member in hong kong and a member in singapore compared the same dose and came out about forty percent apart#asia · 2025-10-08triple_ag_tomi was wrong about japanese pricing by a factor of two when i quoted it in here, because i was quoting a clinic and somebody…#asia · 2025-10-08underfill_umadoes anyone in hong kong want to compare prices#asia · 2025-10-08underfill_umagetting seen in korea was faster than any route a uk member described at the time we were both describing it#asia · 2025-10-08underfill_umakorea has a clinic culture where this is straightforward to obtain, and members reported that as both a convenience and a…#asia · 2025-10-08underfill_umathe indian landscape is qualitatively different from research supply, it is a licensed pharmaceutical industry, and that is…#asia · 2025-10-08endotoxin_eda korean member said their clinic visit took under an hour end to end, which is not a claim about the quality of the assessment#asia · 2025-10-08manila_meniscusas of about a year ago korea had the shortest path from deciding to starting of anywhere members here had described, i could…#asia · 2025-10-11peak_splitthe honest position on india is that i have seen good material and bad material and the paperwork told me nothing either way a…#asia · 2025-10-11hydrate_hanai was wrong about japanese pricing by a factor of two when i quoted it in here, because i was quoting a clinic and somebody…#asia · 2025-10-11underfill_umaindia has a real generics manufacturing base and a real domestic market. what a specific product is, and whether it matches…#asia · 2025-10-11snac_and_waterkorea is fast#asia · 2025-10-11peak_splitanyone in japan paying out of pocket and what does that look like#asia · 2025-10-11factory_direct_fikorea is fast#asia · 2025-10-14factory_direct_fijapan approved it for both indications a while ago as i understood it, and the approval did not make it cheap#asia · 2025-10-14sgp_subqthe honest position on india is that i have seen good material and bad material and the paperwork told me nothing either way#asia · 2025-10-14factory_direct_fiis japan expensive because of the approval or in spite of it#asia · 2025-10-14factory_direct_fia member in hong kong and a member in singapore compared the same dose and came out about forty percent apart, happy to be…#asia · 2025-10-14sgp_subqright so as of about a year ago korea had the shortest path from deciding to starting of anywhere members here had described#asia · 2025-10-14tokyo_taperare the indian products the same compounds or something else entirely#asia · 2025-10-14